Table of Contents Author Guidelines Submit a Manuscript

Familial Parkinson’s Disease / Parkinsonism

Call for Papers

Parkinson’s disease (PD) is the second most common neurodegenerative disorder characterised by parkinsonism (bradykinesia, resting tremor, rigidity, and postural instability) with good response to L-dopa. Although the majority of PD cases are sporadic, it is now clear that genetic factors contribute to the pathogenesis of PD. Indeed, PARK 1-18 loci have been identified in typical and atypical parkinsonism. Knowledge and understanding of these conditions have led to the development of animal models, successful therapies, and novel tools to characterize these clinical conditions and provide better care to patients.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to understand the molecular pathology underlying parkinsonism, the development of strategies to treat these conditions, and the evaluation of outcomes. We are particularly interested in articles describing the new modalities for clinical characterization of PD / parkinsonism and advances in molecular genetics and molecular diagnostics. Potential topics include, but are not limited to:

  • Advances in genetic findings of each locus or causative gene for PD / parkinsonism (PARK1-18: SNCA, Parkin, UCH-L1, PINK1, DJ-1, LRRK2, ATP13A2, HtrA2/Omi, PLA2G6, FBXO7, VPS35, and EIF4G1; SCA2, DCTN1, ....)
  • Known genetic risk factors for PD / parkinsonism (GBA, LRRK2, ..)
  • Interaction between genetic and environmental factors in PD / parkinsonism
  • Latest technologies for genetic testing, clinical evaluation, and measuring outcomes
  • Role of each molecule
  • Findings about disease mechanism and pathogenesis
  • Genetic testing and therapeutic strategy for PD / parkinsonism

Before submission authors should carefully read over the journal's Author Guidelines which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

Manuscript DueFriday, 23 May 2014
First Round of ReviewsFriday, 15 August 2014
Publication DateFriday, 10 October 2014

Lead Guest Editor

  • Hiroyuki Tomiyama, Department of Neurology / Department of Neuroscience for Neurodegenerative Disorders, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo, Tokyo 113-8421, Japan

Guest Editors